Recherche dans la base bibliographique AFSGT

Il y a 107 documents disponibles avec le champ Nature du document = "Traitement" : (cliquez dans pour voir le rÉsumÉ)

  1. Clonazepam in Gilles de la Tourette 's syndrome (multiple tic disorder)
    Auteur: ABUZZAHAB FS, HOPPER H
    Source: European journal of clinical pharmacology 36, suppl A 325, abstract n° PP, 1989
  2. Clinical pharmacy case reports: Tourette's syndrome - Treatment with clonidine, a central acting alpha - adrenergic agonist.
    Auteur: AHSANUDDIN K, HALL K, PROSEN H
    Source: University of Manitoba
  3. La rispÉridone dans le traitement de la psychose parkinsonienne
    Auteur: ANGUENOT A, GIL R, SENON JL, COUDERQ C, NEAU JP
    Source: Annales de psychiatrie, N° 1, 41-47, 1998
  4. Compulsive personality and serotonergic drugs
    Auteur: ANSSEAU M, TROISFONTAINES B, PAPART P, VON FRANCKELL R
    Source: Psychiatric Unit centre hospitalier universitaire de Liège, domaine universitaire du Sart Tilman
  5. IntÉrêt du pergolide dans le traitement de la maladie de Parkinson
    Auteur: BARROCHE G, GEHIN P, VESPIGNANI H, ARTUS O, ZIEGLER F, WEBER M
    Source: Annales mÉdicales de Nancy et de l'Est, communication prÉsentÉe à la sociÉtÉ de MÉdecine de Nancy le 9 mars 1983
  6. Relaxation therapy in Tourette Syndrome : a pilot study
    Auteur: BERGIN A, WARANCH HR, BROWN J et al
    Source: Pediat Neurol, 1998, 18, 2, 136-142
  7. Une maladie des tics ? Abord par la thÉrapeutique de relaxation
    Auteur: BOUNES M
    Source: Sem Hop Paris, 1986, 62, 14, 973-975
  8. RispÉridone as a treatment for Tourette's syndrome
    Auteur: BRUUN RD, BUDMAN CL
    Source: Journal of clinical psychiatry, 57 (1): 29-31,
  9. Opiate therapy and self-harming behavior in Tourette's syndrome
    Auteur: BRUUN R, KURLAN R
    Source: Mov Disord, 1991, 6, 2, 184-185
  10. New TS treatment
    Auteur: BUCKINGHAM D, GAFFNEY G
    Source: J Am Acad Child adolesc Psychiatry, 1993, 32, 1, 224
  11. Competing responses for the traitment of Tourette syndrome and tics disorders
    Auteur: CARR JE
    Source: Behav Res Ther, 1995, 33, 4, 455-456
  12. A brief behavior therapy protocol for Tourette syndrome
    Auteur: CARR JE, BAILEY JS
    Source: J. Behav. Ther. Exp Psychiat, vol 27, n° 1, 33-40, 1996
  13. Sequential use of opioid antagonists and agonists in Tourette's syndrome
    Auteur: CHAPELL PB
    Source: Lancet, 1994, 343, 556
  14. Guanfacine treatment of comorbid Attention - Deficit Hyperactivity Disorder and Tourette's Syndrome: Preliminary clinical experience
    Auteur: CHAPELL PB, RIDDLE MA, SCAHILL L et al
    Source: J Am Acad Child Adolesc Psychiatry, 1995, 34, 9, 1140-1146
  15. Future therapies of Tourette syndrome
    Auteur: CHAPELL PB, SCAHILL LD, LECKMAN JF
    Source: Neurol Clin North Am, 1997, 15, 2, 429-450
  16. Clonidine ameliorates Gilles de la Tourette syndrome
    Auteur: COHEN DJ, DELTOR J, YOUNG G, SHAYWITZ BA
    Source: Arch Gen Psychiatry, Vol 37, Dec 1980
  17. Clonidine in Tourette's syndrome
    Auteur: COHEN DJ, NATHANSON JA, YOUNG JG, SHAYWITZ BA
    Source: the Lancet, sept 15, 1979
  18. A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder
    Auteur: COTTRAUX J, MOLLARD E, BOUVARD M, MARKS I, SLUYS M, NURY AM, DOUGE R, CIALDELLA P
    Source: International Clinical Psychopharmacology, 1990,5,17-30
  19. Tics and rispÉridone
    Auteur: DIANTONIIS M, HENRY KM, PARTRIDGE PAH et al
    Source: J Am Acad Child Adolesc Psychiatry, 1996, 35, 7, 839-840
  20. Treatment of Gilles de la Tourette syndrome with Clonazepam
    Auteur: DION Y
    Source: Canadian College of Neuropsychopharmacology, CCNP, May 19-22, p.w-17, 1987
  21. Treatment of Gilles de la Tourette syndrome with Clonazepam
    Auteur: DION Y, CHOUINARD G
    Source: Canadian psychiatric association, 38 th annual meeting, Halifax, September 28-30, abstract n°72, p 119, 1988
  22. Guide pratique des mÉdicaments. 18° Édition*DODICK D, ADLER CH Tourette's syndrome: current approaches to recognition and management
    Auteur: DOROSZ P
    Source: Postgrad Med, 1992, 5, 299-308
  23. Indications de la clonidine en psychiatrie de l'enfant
    Auteur: DOLLFUS S
    Source: EncÉphale, 1993, 19, 83-87
  24. Traitement chimiothÉrapeutique des tics
    Auteur: DOLLFUS S
    Source: Ann Psychiatr, 1993, 8, 1, 18-23
  25. Differential effects of transdermal nicotine patch on the symptoms of Tourette's syndrome
    Auteur: DURSUN SM, BIRD R, REVELEY MA
    Source: Br J Clin Pharmacol, 1995, 39, 1, 100P-101P
  26. Longlasting improvement of Tourette's syndrome with transdermal nicotine
    Auteur: DURSUN SM, REVELEY MA, BIRD R et al
    Source: Lancet, 1994, 344, 1577
  27. Buspirone treatment of Tourette's syndrome
    Auteur: DURSUN SM, BURKE JG, REVELEY MA
    Source: The Lancet, Vol 345, may 27, 1995
  28. The efficacy of a dose-escalated application of transdermal nicotine plus sulpiride in Tourette's syndrome
    Auteur: DURSUN SM, REVELEY MA
    Source: Eur Psychiatry, 1996, 11, 4, 204-206
  29. Longlasting improvement of Tourette's syndrome with transdermal nicotine
    Auteur: DURSUN SM, REVELEY MA, BIRD R et al*
    Source: Lancet, 1994, 344, 1577
  30. Dose - escalated application of transdermal nicotine in Tourette's syndrome
    Auteur: DURSUN SM, REVELEY MA, STIRTON RF
    Source: J psychopharmacol, 1995, 9, 3, suppl, 98
  31. The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours : preliminary clinical experience
    Auteur: EAPEN V, TRIMBLE MR, ROBERTSON MM
    Source: Prog NeuroPsychopharmacol Biol Psychiatry, 1996, 20,737-743
  32. Talipexole and adult Gilles de la Tourette's syndrome : double-blind, placebo-controlled clinical trial
    Auteur: GOETZ CG, STEBBINS GT, THELEN JA
    Source: Movement disorders, Vol 9, n°3, 315-317, 1994
  33. Biological approaches to treatment resistant obsessive compulsive disorder
    Auteur: GOODMAN WK, DOUGLE CJ, BARR LC, ARONSON SC, PRICE LH
    Source: J Clin Psychiatr 54:6 (suppl), juin 1993
  34. Clomipramine efficacy for Tourette syndrome and major depression: a case study
    Auteur: IANCU I, KOLTER M, BLEICH A et al
    Source: Biol Psychiatry, 1995, 38, 6, 407-409
  35. Clozapine in tardive Tourette Syndrome
    Auteur: JAFFE E, TREMEAU F, SHARIF Z et al
    Source: Biol Psychiatry, 1995, 38, 3, 196-197
  36. Botulinum toxin in the treatment of tics In Therapy with botulinum Toxin ed by Jankovic J and Hallet M
    Auteur: JANKOVIC J
    Source: New York: M Dekker, 1994, 503-509
  37. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette’s syndrome
    Auteur: JANKOVIC J, GLAZE DG, FROST JD
    Source: Neurology 34, n°5, 688-92, 1984
  38. Botulinum toxin in movement disorders
    Auteur: JANKOVIC J
    Source: Current Opin Neurol, 1994, 7, 358-366
  39. Botulinum toxin in the treatment of distonic tics
    Auteur: JANKOVIC J
    Source: Mov Disord, 1994, 9, 3, 347-349
  40. Deprenyl in attention deficit associated with Tourette's syndrome
    Auteur: JANKOVIC J
    Source: Arch neurol, 1993, 50, 3, 286-288
  41. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette’s syndrome
    Auteur: JANKOVIC J, GLAZE DG, FROST JD
    Source: Neurology 34, n°5, 688-92, 1984
  42. tetrabenazine therapy of dystonia, chorea, tics and other dyskinesias
    Auteur: JANKOVIC J, ORMAN J
    Source: Neurology, 1988, 38, 391-394
  43. Cholinergic strategies in Tourette Syndrome: an open label trial of tarine hydrochloride
    Auteur: JUNCOS, VICKI, ROBERTS, ATLANTA GA, TRACY, WALDECK, ATHENS, GA
    Source: Neurology 48, March 1997(S69.003), vol 48 n°3, Suppl 2
  44. A case of Gilles de la Tourette's syndrome treated with clonazepam
    Auteur: KAIM B
    Source: brain research bulletin, Vol 11, N° 2, 213-214, 1983
  45. Clonidine in Tourette syndrome
    Auteur: KEITH IG, WILLIAMS A, NICOL AR
    Source: The Lancet, January 31, 1981
  46. The treatment of obsessive compulsive disorder in Tourette's syndrome. In: Handbook of Tourette's Syndrome and related tics and behavorial disorders ed by Kurlan R
    Auteur: KING RA, VITULANO LA, RIDDLE MA
    Source: New York: M Dekker, 1993, 401-421
  47. Future therapies In: Handbook of Tourette's syndrome and related tics and behavorial disorders ed by Kurla R
    Auteur: KORCZYN AD
    Source: New York: M DEKKER, 1993, 481-490
  48. Facial tics
    Auteur: KOWAL L
    Source: Aust Fam Physician, 1994, 24, 10, 1870-1871
  49. Treatment of tics
    Auteur: KURLAN R
    Source: Neurol Clin North Am, 1997, 15, 2, 403-409
  50. Future direction of research in Tourette syndrome
    Auteur: KURLAN R
    Source: Neurol Clin North Am, 1997, 15, 2, 451-456
  51. Pergolide: a review of its pharmacological properties and therapeutic potential in Parkinson's desease.
    Auteur: LANGTRY HD, CLISSOLD SP
    Source: Drugs 39(3):491-506;ADIS Drug Information Services,Auckland,New Zeland
  52. On the use of clonidine and thioproperazine in a woman with Gilles de la Tourette’s Disease
    Auteur: LECHIN F, VAN DER DIJS B, GOMEZ F, ACOSTA E, AROCHA L
    Source: Biological Psychiatry, Vol 17, N°1, 1982.
  53. Growth hormone response to clonidine in children ages 4-17: Tourette's syndrome vs. children with short stature
    Auteur: LECKMAN JF, COHEN DJ, GERTNER JM, ORT S, HARCHERIK DF
    Source: Journal of the American academy of child psychiatry, 23, 2:174-181
  54. Clonidine treatment of Gilles de la Tourette's syndrome
    Auteur: LECKMAN JF, HARDIN MT, RIDDLE MA et al
    Source: Arch Gen Psychiatry, 1991, 48, 324-328
  55. Essai de la carbamazÉpine dans le syndrome de Gilles de la Tourette
    Auteur: LE HEUZEY MF, GERARD CL, DUGAS M
    Source: Sem Hôp Paris 1994; 70: n°5-6, 176-179
  56. Pharmacotherapy beyond the catecholaminergic system
    Auteur: LEWITT PA
    Source: Handbook of Tourette's syndrome related tic and behavorial disorders Ed by R Kurlan, 1993
  57. Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide
    Auteur: LIPINSKI JF, SALLEE FR, JACKSON C, SETHURAMAN G
    Source: Mov disord, vol 12 (3), 402-407, ISSN:0885-3185, 1997
  58. rispÉridone
    Auteur: LIVINGSTON MG
    Source: Lancet, 1994, 343, 457-460
  59. rispÉridone treatment of children and adolescents with chronic tic disorders: a preliminary report
    Auteur: LOMBROSO PJ, SCAHILL L, KING RA et al
    Source: J Am Acad Child Adolesc Psychiatry, 1995, 34, 9, 1147-1152
  60. Fluoxetine use in Tourette syndrome
    Auteur: LUM L
    Source: Can J Hosp Pharm, 1991, 44, 6, 301
  61. Blood choline and response to clonazepam and halopÉridol in Tourette's syndrome
    Auteur: MENKANGAS JR, MENKANGS KR, KOPP U, HANIN I
    Source: Acta psychiatra. Scand. 72, n°4, 395-399, 1985
  62. halopÉridol therapy in Tourette's syndrome: neurophysiological, biochimical and behavorial correlates
    Auteur: MESSINA FS, KNOPP W, VANECKO S, O'BRIEN V, CORSON A
    Source: Life sciences, Vol 10, Part I, 449-457, 1971
  63. Methadone treatment of Tourette's disorder
    Auteur: MEULDIJK R, COLON EJ
    Source: Am J Psychiatry, 1992, 149, 1, 139-140
  64. Tolerance of tetrabenazine during long-term treatment
    Auteur: MIKKELSEN BO
    Source: Acta neurol scand, 68:57-60, 1983
  65. Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette's syndrome and other motor disorders
    Auteur: MOSS DE, MANDERSCHEID PZ, MONTGOMERY SP, NORMAN AB, SANBERG PR
    Source: Life sciences, Vol 44, pp, 1521-1525, pergamon press
  66. Tardive Tourette's syndrome treated with clonidine and mesoridazine
    Auteur: MUNETZ MR, SLAWSKY RC, NEIL JF
    Source: Psychosomatics, March 1985, Vol 26, N°3
  67. Pediatric psychopharmacology : Tourette's syndrome
    Auteur: PERRY PJ, ALEXANDER B, ELLINGROD VL
    Source: The virtual Hospital: Clinical Psychophamacology Seminar 1996-1997, Peer Review Status: none http://www.vh.org/Providers/Conferences/CPS/42.html
  68. Steroid hormones and Tourette's syndrome: early experience with antiandrogen therapy
    Auteur: PETERSON BS, LECKMAN JF, SCAHILL L, NAFTOLIN F, KEEFE D, CHAREST NJ, KING RA, HARDIN MT, COHEN DJ
    Source: Journal of clinical psychopharmacology, vol 14, n° 2, 131-135,
  69. Clomipramine efficacy for tics, obsessions, and compulsions in Tourette's syndrome and obsessive compulsive disorder: a case study
    Auteur: RATZONI G, HERMESH H, BRANDT N et al
    Source: Biol Psychiatry, 1990, 27, 95-98
  70. Combined pharmacotherapy of Gilles de la Tourette's syndrome
    Auteur: REGEUR I, PAKKENBERG B, PAKKENBERG H, FOQ R
    Source: Acta Neurologica scandinavica 65, Suppl.90, 308-309, 1982
  71. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders preliminary clinical experience
    Auteur: RIDDLE MA, HARDIN MT, KING R et al
    Source: J Am Acad Child Adolesc Psychiatry, 1990, 29, 1, 45-48
  72. Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome
    Auteur: RIDDLE MA, LECKMAN JF, HARDIN MT ANDERSON GM, COHEN DJ
    Source: Am J Psychiatry, 145: 9, sept. 1988
  73. RispÉridone in the treatment of Tourette's syndrome: a retrospective case note study
    Auteur: ROBERTSON MM, SCULL DA, EAPEN V et al
    Source: J Psychopharmacol, 1996, 10, 4, 317-320
  74. Prolactin monitoring of halopÉridol and pimozide treatment in children with Tourette's syndrome
    Auteur: SALLEE FR, DOUGHERTY D, SETHURAMAN G, VRINDAVANAM N
    Source: Biol. Psychiatry, 1996, 40, 1044-1050
  75. Relative efficacy of halopÉridol and pimozide in children and adolescents with Tourette's disorder
    Auteur: SALLEE FR, NESBITT L, JACKSON C et al
    Source: Am J Psychiatry, 1997, 154, 1057-1062
  76. Botulism toxin for refractory vocal tics
    Auteur: SALLOWAY S, STEWART CF, ISRAELI L et al
    Source: Mov Disord, 1996, 11, 6, 746-748
  77. Nicotine gum and halopÉridol in Tourette's syndrome
    Auteur: SANBERG PR, FOGELSON HM, MANDERSCHEID PZ et al
    Source: Lancet, 1988, 592
  78. Beneficial effects of imipramine on Tourette's syndrome
    Auteur: SANDYK R, BAMFORD CR
    Source: Intern J Neurosci, 1988, 39, 27-29
  79. Clozapine in Tourette's syndrome
    Auteur: SCHMIDER J
    Source: J Clin Psychopharmacol, 1998, 18, 1, 88-89
  80. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
    Auteur: SCOTT BL, JANKOVIC J, DONOVAN DT
    Source: Mov Disorders, 1996, 11, 4, 431-433
  81. Un cas de maladie des tics de Gilles de la Tourette guÉri par le R 1625
    Auteur: SEIGNOT JN
    Source: Ann MÉdico Psychol, 1961, 119, 578-579
  82. Novel use of tramadol hydrochloride in the treatment of Tourette's syndrome
    Auteur: SHAPIRO NA, Mc CONVILLE BJ, PAGNUCCO ML et al
    Source: J Clin Psychiatry, 1997, 58, 4, 174-175
  83. Neuroleptic drugs In Handbook of Tourette's syndrome and related tic and behavorial disorders ed by Kurlan R
    Auteur: SHAPIRO AK, SHAPIRO ES
    Source: New York: M Dekker, 1993, 347-375
  84. Treatment of Gilles de la Tourette's Syndrome with clonidine and neuroleptics
    Auteur: SHAPIRO AK, SHAPIRO ES, EISENKRAFT GJ
    Source: arch Gen psychiatry; Vol 40, Nov 1983
  85. Treatment of tic disorders
    Auteur: SHAPIRO AK, SHAPIRO ES, YOUNG TG, FEINBERG TE,
    Source: Gilles de la Tourette, 2nde Édition, Raven Press NY, 1988, 423-449
  86. RispÉridone in Gilles de la Tourette's syndrome
    Auteur: SHULMAN LM, SINGER C, WEINER WJ
    Source: Neurology, 1995, 45, 1419
  87. Transdermal nicotine for Tourette's syndrome
    Auteur: SHYTLE RD, SILVER AA, PHILIPP MK et al
    Source: Drug Dev Res, 1996, 38, 290-298
  88. Transdermal nicotine patch and potentiation of halopÉridol in Tourette's syndrome
    Auteur: SILVER AA, SANBERG PR
    Source: Lancet, 1993, 342, 182
  89. Case study: long term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome
    Auteur: SILVER AA, SHYTLE RD, PHILIPP MK et al
    Source: J Am Acad Child Adolesc Psychiatry, 1996, 35, 12, 1631-1636
  90. Serotoninergic agents in the treatment of Gilles de la Tourette's syndrome
    Auteur: SILVESTRI R, RAFFAELE M, DE DOMINICO P, TISANO A, LAGANA A, DI PERRI R
    Source: Acta neurologica, 16 (1-2) : 58-63, feb-Apr 1994
  91. The treatment of attention deficit hyperactivity disorder in Tourette's syndrome: a double blind placebo - controlled study with clonidine and desipramine
    Auteur: SINGER HS, BROWN J, QUASKEY S et al
    Source: Pediatrics, 1995, 95, 1, 74-81
  92. Desipramine treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome
    Auteur: SPENCER T, BIEDERMAN J, KERMAN K et al
    Source: J Am Acad Child Adolesc Psychiatry, 1993, 32, 2, 354-360
  93. Bupropion exacerbates tics in children with attention deficit hyperactivity disorder and Tourette's syndrome
    Auteur: SPENCER T, BIEDERMAN J, STEINGARD R et al
    Source: J Am Acad Child Adolesc Psychiatry, 1993, 32, 1, 211-214
  94. Tricyclic antidepressant treatment of children with ADHD and tics disorders
    Auteur: SPENCER T, BIEDERMAN J, WILENS T
    Source: J Am Acad Chid Adolesc Psychiatry, 1994, 33, 8, 1203-1204
  95. Nortriptyline treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome
    Auteur: SPENCER T, BIEDERMAN J, WILENS T
    Source: J am Acad Child Adolesc Psychiatry, 1993, 32, 1, 205-210
  96. Risperdone for Tourette's syndrome
    Auteur: STAMENKOVIC M, ASCHAUER H, KASPER S
    Source: Lancet, 1994, 344, 1577-1578
  97. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD
    Auteur: STEINGARD RJ, GOLDBERG M, LEE D et al
    Source: J Am Acad Child Adolesc Psychiatry, 1994, 33, 3, 394-399
  98. Traitement par le tiapride d'un enfant prÉsentant des tics importants
    Auteur: TAMET CM, BERGER M, LANG F
    Source: Rev Fr Psychiatrie, 1984, 2, 42-45
  99. Traitement de la maladie de Gilles de la Tourette par l'amisulpride
    Auteur: TRILLET M, MOREAU T, DALERY J, DE VILLARD R, AIMARD G
    Source: La presse mÉdicale, 19, n° 4, 3 fÉvrier 1990
  100. Vocal tics in Gilles de la Tourette syndrome treated with notulinum toxin injections
    Auteur: TRIMBLE MR, WHURR R, BROOKES G et al
    Source: Mov Disord, 1998, 13, 3, 617-619
  101. Clonazepam, halopÉridol and Clonidine in tics disorders
    Auteur: TRUONG DD, BRESSMAN S, SHALE H et al
    Source: South Med J, 1988, 81, 9, 1103-1105
  102. Serotonin-dopamine antagonist and Gilles de la Tourette's Syndrome: an open pilot dose titration study with risperdone
    Auteur: VAN DER LINDEN C, BRUGGEMAN R, VAN WOERKOM T
    Source: Mov Disord, 1994, 9, 6, 687-688
  103. The long term treatment of depressed patients with fluvoxamine (FL).
    Auteur: VARDY A, HOLLAND R
    Source: Proc 18th Coll int neuro-psychopharmacology cong., Nice, 28 June -2 July 1992, Clin Neuropharmacol 1992, 15 (suppl 1, Pt B): 333 B (Abs P-19-188)
  104. Pergolide mesylate
    Auteur: VIDAL
    Source: Vidal, 1166
  105. SYNDROME DE GILLES DE LA TOURETTE ET NEUROTRANSMETTEURS
    Auteur: VIDAL
    Source: Paris, OVP, 1998
  106. Les cannabinoïdes rÉduisent les symptômes du Syndrome de Gilles de la Tourette
    Auteur: MUELLER-VAHL
    Source: Pharmacopsychiatry 2002 ;33 :57-61
  107. Les stimulants peuvent traiter l'ADHD, les tics
    Auteur: NASS et BRESSMAN
    Source: MedscapeWire,Neurology, 26 FÉvrier 2002

Base bibliographique maintenue par AFSGT

remonter